Introduction
The ACC/AHA Task Force on Practice Guidelines herein revises and updates the original "Guidelines for Coronary Angiography," published in 1987 The frequent and still-growing use of coronary angiography, its relatively high costs, its inherent risks and the ongoing evolution of its indications have given this revision urgency and priority.
The expert committee appointed included private practitioners and academicians. Committee members were selected to represent both experts in coronary angiography and senior clinician consultants. Representatives from the family practice and internal medicine professions were also included on the committee [1] .
Definitions
Coronary angiography is defined as the radiographic visualization of the coronary vessels after the injection of radiopaque contrast media. The radiographic images are permanently recorded for future review with either 35 mm cine film or digital recording. Percutaneous or cutdown techniques, usually from the femoral or brachial artery, are used for insertion of special intravascular catheters. Coronary angiography further requires selective cannulation of the ostium of the left and right coronary arteries and, if present, each saphenous vein graft or internal mammary artery graft to obtain optimal selective contrast injection and imaging. Numerous specialized catheters have been designed for this purpose. Physicians performing these procedures must be technically proficient in all aspects of the procedure and have a complete understanding of the clinical indications and risks of the procedure and of coronary anatomy, physiology and pathology. It is also important that these physicians understand the fundamentals of optimal radiographic imaging and radiation safety. Coronary angiography is usually performed as part of cardiac catheterization, which may also involve angiography of other vessels or cardiac chambers, and hemodynamic assess-discomfort due to myocardial ischemia, often described as a transient squeezing, pressurelike precordial discomfort. Angina is generally provoked by physical effort (particularly during the postprandial state), with exposure to cold environment or by emotional stress. The discomfort on effort is relieved by rest, its duration being a matter of minutes. The ease of provocation, frequency and duration of episodes may remain relatively unchanged in individuals for extended time periods, leading to the term "stable angina pectoris." 
Recommendations for Coronary Angiography in Patients With

Unstable angina
The acute coronary syndromes include unstable angina, non-Q-wave MI, and acute Q-wave MI. The diagnosis of unstable angina has been complicated by a broad range of presentations that can vary between atypical chest pain and acute MI. An expert panel of clinicians attempted to clarify the definition of unstable angina in the recently published "Clinical Practice Guideline for Unstable Angina" [129, 130] . Three possible presentations are described:
• Symptoms of angina at rest (usually prolonged 20 minutes);
• New-onset (<2 months) exertional angina of at least CCS class III in severity;
• Recent (<2 months) acceleration of angina as reflected by an increase in severity of at least one CCS class to at least CCS class III. [4, 5] Variant angina, non-Q-wave MI and recurrent angina24 hours after MI are considered part of the spectrum of unstable angina. However, in this document, non-Q-wave MI is discussed in the section on acute MI. [4, 5] Recommendations [6, 7] . Considerable data exist showing that coronary reperfusion can be accomplished either by intravenous thrombolytic therapy or direct mechanical intervention within the infarct-related artery. Because the benefit obtained is directly linked to the time required to reestablish normal distal blood flow [8] [9] [10] , rapid triage decisions are mandatory, and delays in instituting reperfusion therapy must be minimized. The "ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction" provide a comprehensive discussion of the indications, contraindications, advantages, and disadvantages of thrombolytic therapy and direct coronary angioplasty [11] . Although it is not the purpose of these guidelines to re-ex-amine in detail the merits of these two reperfusion strategies, this is a rapidly evolving area, and some new information exists. Class II: None.
Class III: None.
Hospital-management phase of acute MI
The hospital-management phase of acute MI can encompass several clinical situations. Some patients with acute MI present too late in their course to be candidates for reperfusion therapy, and in others, the occurrence of infarction may not be appreciated at he time of presentation. These groups skip the acute-treatment phase of MI and enter the hospital-management phase directly. During the hospital management phase, the actions of the clinician are driven by the consequences of the infarction, such as congestive heart failure, hemodynamic instability, recurrent ischemia or arrhythmias. Although it is still convenient to divide patients into those with Q-wave and non-Q-wave infarctions, some indications for coronary angiography are common to all patients with MI regardless of how they have been treated initially and whether or not Q waves ultimately develop. 
Class IIa
None.
Class IIb
During left-heart catheterization performed for hemodynamic evaluation before aortic or mitral valve surgery in patients without preexisting evidence of coronary disease, multiple CAD risk factors or advanced age. 
Congenital heart disease
Although there are no large trials to support its use, coronary angiography is performed in congenital heart disease for two broad categorical indications. The first indication is to assess the hemodynamic impact of congenital coronary lesions (375). The second is to assess the presence of coronary anomalies, which by themselves may be innocent but whose presence, if unrecognized, may lead to coronary injury during the correction of other congenital heart lesions. Congenital anomalies with hemodynamic significance include congenital coronary artery stenosis or atresia, coronary artery fistula [11] , anomalous left coronary artery arising from the pulmonary artery [12] , and anomalous left coronary artery arising from the right coronary artery or right sinus of Valsalva and passing between the aorta and right ventricular outflow tract [13] . Patients with congenital coronary stenosis may present with angina or unexplained sudden death in childhood, whereas patients whose left coronary passes between the pulmonary artery and aorta often have the same symptoms later in life. Patients with a coronary arteriovenous fistula often present with a continuous murmur or may have unexplained angina or congestive heart failure. Anomalous origin of the left coronary artery from the pulmonary artery should be suspected when there is unexplained MI or heart failure in early childhood. Other coronary anomalies of position or origin may cause no physiologic abnormality by themselves. Some, such as origin of the circumflex artery from the right sinus of Valsalva, are not associated with other congenital anomalies and present only as incidental findings and are significant only because they complicate the performance and interpretation of coronary angiograms.
Recommendations for use of coronary angiography in patients with congenital heart disease Class I
1. Before surgical correction of congenital heart disease when chest discomfort or noninvasive evidence is suggestive of associated CAD. 
Class IIa
Before corrective open heart surgery for congenital heart disease in an adult whose risk profile increases the likelihood of coexisting coronary disease. (Level of Evidence: C)
Class IIb
During left-heart catheterization for hemodynamic assessment of congenital heart disease in an adult in whom the risk of coronary disease is not high. (Level of Evidence: C)
Class III
In the routine evaluation of congenital heart disease in asymptomatic patients for whom heart surgery is not planned. (Level of Evidence: C)
Congestive heart failure
Systolic dysfunction
Although it was once believed that myocardial ischemia was either short-lived and resulted in little or no muscle dysfunction or resulted in infarction with permanent damage, it is now clear that a middle state may exist in which chronic ischemic nonfunctioning myocardium is present, to which function may return after myocardial revascularizations [15, 16] . This intermediate state has been termed "myocardial hibernation." Although most cases of myocardial dysfunction resulting from CAD are probably irreversible when due to infarction and subsequent deleterious ventricular remodeling (ischemic cardiomyopathy) [17] , some patients with hibernating myocardium have been shown to experience a doubling of resting ejection fraction with resolution of congestive heart failure after coronary revascularization [18, 19] . However, in most cases of hibernation, a more modest improvement in ejection fraction of 5% occurs after revascularization [20] .
Diastolic dysfunction
Isolated diastolic dysfunction is the cause of heart failure in 10% to 30% of affected patients. This disorder is common in older patients with hypertension and often is suspected because of echocardiographically detected concentric left ventricular hypertrophy, normal systolic function and abnormal transmitral flow velocity patterns [21] . However, in some patients with normal systolic function, the abrupt onset of pulmonary edema raises the suspicion that transient ischemia was the cause of decompensation, because elderly patients with hypertension have, by definition, at least two risk factors for coronary disease. In these patients, who are often too ill to undergo stress testing, coronary angiography may be necessary to establish or rule out the diagnosis of ischemically related diastolic dysfunction and heart failure.
Recommendations for use of coronary angiography in patients with congestive heart failure Class I
1. Congestive heart failure due to systolic dysfunction with angina or with regional wall motion abnormalities and/or scintigraphic evidence of reversible myocardial ischemia when revascularization is being considered. 
Class III
Congestive heart failure with previous coronary angiograms showing normal coronary arteries, with no new evidence to suggest ischemic heart disease. (Level of Evidence: C)
Aortic dissection
The need for coronary angiography before surgical treatment for aortic dissection remains controversial because there are no large trials to support its use. In young patients with dissection due to Marfan syndrome or in dissection in peripartum females, coronary angiography is unnecessary unless there is suspicion that the dissection has affected one or both coronary ostia. In older patients, in whom dissection is usually related to hypertension, coronary angiography is often necessary, especially if patients are suspected of having coronary disease because of a history of angina or objective evidence of myocardial ischemia. In patients who have no history of coronary disease, the indications for coronary angiography are much less certain. Because of the high incidence of coronary disease in older patients with dissection, some studies have advocated routine coronary angiography [22] , whereas others have found increased mortality when angiography is performed [23] .
Hypertrophic cardiomyopathy
Significant CAD due to atherosclerosis is found in 25% of patients aged >45 years with hypertrophic cardiomyopathy [26] . Because symptoms due to CAD and hypertrophic cardiomyopathy are similar, patients with ischemic symptoms not well controlled with medical therapy may require coronary angiography to resolve the cause of chest pain. Coronary angiography also is indicated in patients with chest discomfort and hypertrophic cardiomyopathy in whom a surgical procedure is planned to correct outflow tract obstruction.
Arteritis
Some patients with inflammatory processes affecting the aorta, such as Takayasu arteritis, may have coronary artery involvement requiring coronary artery revascularization. In such patients, coronary angiography is required before the surgical procedure. Kawasaki disease can result in coronary artery aneurysm and coronary artery stenosis producing myocardial ischemia or silent occlusion and may require coronary angiographic assessment [24, 25] .
Chest trauma
Patients who have an acute MI shortly after blunt or penetrating chest trauma may have atherosclerotic CAD, but coronary artery obstruction or damage has been reported in the absence of coronary atherosclerosis [27] . Furthermore, myocardial contusion may simulate acute MI. Infrequently, coronary angiography is indicated in the management of such patients.
Recommendations for use of coronary angiography in other conditions
Class I
1. Diseases affecting the aorta when knowledge of the presence or extent of coronary artery involvement is necessary for management (e.g., aortic dissection or aneurysm with known coronary disease). 4. Before surgery for aortic aneurysm/dissection in patients without known coronary disease.
Recent blunt chest trauma and suspicion of acute MI, without evidence of preexisting CAD. (Level of Evidence: C)
Special considerations regarding coronary angiography
Accuracy
Cineangiographic images of coronary arteries have been the principal clinical tool for determining the severity of coronary luminal stenosis. Modern angiographic equipment has a resolution of four to five line pairs per millimeter with a six-inch field of view, the usual image magnification for coronary angiography [28] . Validation studies that use known phantoms show a high correlation between actual size and that measured by quantitative coronary angiography (QCA) (r = 0.95) [29] [30] [31] [32] . The resolution of these phantom studies in-dicates the precision of coronary angiography to be 0.02 to 0.04 mm. Factors that limit resolution in the clinical setting include grainy films from "quantum mottling" and motion artifact that, in a clinical setting, limit resolution to 0.2 mm, far less than that realized from static images of known phantoms. Other factors, such as angulation, overlap of vessels and image tube resolution can also influence accuracy in the clinical setting. Nevertheless, the accuracy of coronary angiography does allow for anatomic detail that is not obtainable by current noninvasive or other invasive technology. Only intravascular ultrasound, which is discussed in Appendix C, has an image resolution greater than that of coronary angiography. However, intravascular ultrasound cannot visualize the entire coronary tree nor define the anatomic course of the coronary vessels. It is also limited by shadowing from heavy calcification and by its inability to image very small vessels or very severe stenosis. In the interventional era, the advantages of digital angiography are important. The image quality provided by digital angiography is better than any common videotape format. Improvements in computer speed and processing capability enable rapid replay of coronary injection sequences, as well as evaluation of the results of each intervention and identification of complications such as intraluminal thrombus and dissection. In many laboratories, the availability of high-quality images during catheterization permits diagnostic and therapeutic catheterization to consist of a single procedure, a capability with significant implications for the cost of interventional procedures. Industry sources now estimate that >75% of existing laboratories are equipped with digital imaging capability.
Digital imaging of coronary angiography
The ACC Cardiac Catheterization Committee is coordinating efforts to develop and promote a standard for archival storage and exchange of digital cardiac angiography. The committee has joined in this common cause with an industry organization, the National Electrical Manufacturers Association (NEMA), and representatives of the American College of Radiology (ACR). The ACR and NEMA have recently released an interim standard known as Digital Imaging Communication in Medicine (DICOM version 3.0).
The initial efforts of the standards committee have focused on adoption of a file format and physical medium for interchange of digital angiographic studies. To transfer images between medical centers, the sender would generate a DICOM-compatible file for review by the receiver. Recently, this working group has chosen a recordable form of the common CD-ROM, termed CD-R, as the official exchange medium. Nearly all equipment vendors have announced support for this format.
Reproducibility
In clinical practice, the degree of coronary artery obstruction is commonly expressed as the percent diameter stenosis. This is done by comparing the diameter of the site of greatest narrowing (minimal lumen diameter) to an adjacent segment assumed to be free of disease. In clinical practice, the most common method used to estimate the percent diameter narrowing is subjective visual assessment. Because vasomotor tone can alter the reference diameter, nitroglycerin is frequently administered before angiography to improve the reproducibility of the measurement. Several studies have shown that measurement of the degree and extent of luminal narrowing correlates with symptoms as well as with assessments of coronary flow reserve (CFR) and abnormalities on treadmill exercise testing, perfusion imaging with Tl or sestamibi, stress echocardiography and fast computerized tomography [33] [34] [35] [36] [37] . In addition, the percent diameter reduction and the number of stenosis of >50% to 70% correlate with long-term outcome [33] [34] [35] [36] [37] .
Limitations
Although coronary angiography is considered the reference standard for anatomic assessment of coronary obstructions, there are limitations to the technique. When luminal narrowings are present on coronary angiography (in the absence of spasm), pathological analyses almost always demonstrate severe atherosclerotic obstruction. Even minor angiographic abnormalities are associated with a poorer long-term outcome than are completely normal appearing angiograms. Coronary angiography has a high predictive value for the presence of CAD when abnormalities are present. However, the converse is not true. A normal coronary angiogram does not exclude atherosclerosis, and in fact, most pathological studies suggest that angiography grossly underestimates the extent and severity of atherosclerosis [38] [39] [40] [41] [42] . Several factors contribute to this discrepancy.
First, angiography depicts coronary anatomy from a planar two-dimensional silhouette of the contrast-filled vessel lumen. However, coronary lesions are often geometrically complex, with an eccentric luminal shape such that one angle of view may misrepresent the extent of narrowing [39] . Two orthogonal angiograms should demonstrate more correctly the severity of most lesions, but adequate orthogonal views are frequently unobtainable because the stenosis may be obscured by overlapping side branches, disease at bifurcation sites, diographic foreshortening or tortuosity. This can be especially difficult in the left main coronary artery, where identifying a significant stenosis is of utmost clinical importance [43] .
Second, an adaptive phenomenon, coronary remodeling," contributes to the inability of coronary angiography to identify mild atherosclerosis [44] . Remodeling was initially observed on histology as the outward displacement of the external vessel wall in vascular segments with significant atherosclerosis. In the early phases of atherosclerosis, this vessel enlargement "compensates" for luminal encroachment, thereby concealing the atheroma from the angiogram. When the atherosclerotic plaque becomes severe, luminal encroachment becomes evident. Although such mild lesions do not restrict blood flow, clinical studies have demonstrated that these minimal or even unseen angiographic lesions represent an important predisposing cause of acute coronary syndromes, including MI [55] .
Third, assessment of luminal diameter narrowing is complicated by the frequent absence of a normal reference segment [56] . Angiography visualizes only the lumen of the vessel and cannot determine if the wall of the reference segment has atherosclerosis [38] [39] [40] [41] [42] . In the presence of diffuse reference segment disease, percent stenosis will predictably underestimate the true amount of diameter narrowing.
Finally, in the setting of percutaneous intervention, the assumptions underlying simple projection imaging of the lumen are further impaired. Necropsy studies and intravascular ultrasound demonstrate that most mechanical coronary interventions exaggerate the extent of luminal eccentricity by fracturing or dissecting the atheroma within the lesion [45] [46] [47] [48] [49] . The angiographic appearance of the postintervention vessel often consists of an enlarged, although frequently "hazy" lumen [46] . In this setting, the lumen size on angiography may overestimate the vessel cross-sectional area and misrepresent the actual gain in lumen size.
Experimental and clinical studies have shown that when percent stenosis is >50%, the ability to increase blood flow in response to metabolic demands is impaired [50] . This augmentation of coronary blood flow to demand is termed the coronary flow reserve. Determination of CFR requires measurement of blood flow at rest and after induction of reactive hyperemia, usually by administration of a coronary vasodilator. Several methods for measurement of CFR in patients have been developed, including intracoronary Doppler flow probes, digital angiography and quantitative PET [51] [52] [53] [54] .
Coronary collaterals can provide significant additional blood flow to territories served by stenotic vessels [58] . In general, collaterals are not evident unless resting ischemia is present, such as that which occurs with a stenosis.90%. In many patients, collateral flow merely restores normal resting blood flow but does not provide adequate flow when metabolic demand increases. The presence of collaterals, however, is associated with preservation of myocardial function after MI, reduced myocardial ischemia on noninvasive stress testing, and reduced ischemia during angioplasty [59, 60] . Paradoxically, a greater ischemic response on noninvasive functional testing with adenosine than with exercise has been reported in the presence of collaterals, presumably due to an increase in the coronary steal phenomenon [61] . Collateral blood flow can only be semiquantified by angiography [62] , and precise assessment of perfusion by angiography is poor. This inability to adequately measure collateral flow is one of the factors that prevent accurate assessment of the functional significance of coronary stenosis by angiography alone [57] .
Contrast agents
For an understanding of the pharmacologic properties and adverse effects of contrast agents, the reader is referred to the 1993 review of the subject by the ACC Cardiovascular Imaging Committee [63] and the 1996 review by Hirshfeld [64] .
Except for a less potent anticoagulant effect, nonionic agents are better tolerated and have fewer side effects than ionic agents [63] . Several randomized trials have compared their use during cardiac angiography. Barrett et al. [65] compared a nonionic low-osmolar contrast agent with an ionic high-osmolar contrast agent. Although adverse events were reduced, severe reactions were confined to patients with underlying severe cardiac disease. These authors supported the use of nonionic low-osmolar agents in these high-risk patients. Steinberg et al. [66] The difference in the incidence of any major contrast reaction is proportional to the New York Heart Association clinical function class, rising from 0.5% for class I patients to 3.6% for class IV patients [68] . Given these observations, it has been suggested that nonionic agents should be reserved for patients who are at high risk for adverse reactions and that ionic agents should be used for all other patients [64] .
Factors that have been associated with high risk of adverse reactions to contrast media include prior adverse reaction to contrast agents, age >65 years, New York Heart Association functional class IV (or hemodynamic evidence of congestive heart failure), impaired renal function (creatinine >2.0 mg/dL), acute coronary syndromes (unstable angina or acute MI) and severe valvular disease (aortic valve area <0.7 cm 2 or mitral valve area <1.25 cm 2 ) [64] . It is recommended that the individual practitioner appropriately assess the cost and benefit relationship when selecting contrast agents in any individual patient and that a strategy of reserving nonionic agents for patients who are at high risk of adverse reactions is prudent and cost-effective. [69] ACC/AHA classifications of class I, II, and III. These classes summarize the indications for coronary angiography as follows: Class I: Conditions for which there is evidence and/or general agreement that this procedure is useful and effective.
Class II:
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of performing the procedure. Class IIa: Weight of evidence/opinion is in favor of usefulness/ efficacy. Class IIb: Usefulness/efficacy is less well established by evidence/opinion. Class III: Conditions for which there is evidence and/or general agreement that the procedure is not useful/effective and in some cases may be harmful. [70, 71] 
Coronary angiography indications
• Unstable angina or Chest pain [uncontrolled with medications or after a heart attack]
• Heart attack
• Aortic Stenosis
• Before a bypass surgery
• Abnormal treadmill test results
• Determine the extent of coronary artery disease
• Disease of the heart valve causing symptoms (syncope, shortness of breath)
• To monitor rejection in heart transplant patients
• Syncope or loss of consciousness in patients with aortic valve disease
• Pain in the Jaw,Neck or Arm
Risks
• Generally the risk of serious complications ranges from 1 in 1,000 to 1 in 500. Risks of the procedure include the following :
• Stroke
• Heart attack
• Irregular heart beats
• Low blood pressure
• Injury to the coronary artery
• Allergic reaction to contrast dye [3] Rare risks and complications include:
• Need for emergency heart surgery or angioplasty.
• A stroke.
• Heart attack.
• Surgical repair of the groin/arm puncture site or blood vessel.
• Abnormal heart rhythm that continues for a long time. This may need an electric shock to correct.
• An allergic reaction to the x-ray dye. [2] Other, less common complications include:
• Arrhythmias. These irregular heartbeats often go away on their own. However, your doctor may recommend treatment if they persist.
• Kidney damage caused by the dye that's used during the test.
• Blood clots that can trigger a stroke,heart stroke, or other serious problems.
• Low blood pressure. [2] Coronary angiography contraindications
• Fever
• Kidney failure or dysfunction
• Problems with blood coagulation (Coagulopathy)
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• Active systemic infection
• Uncontrolled Blood Pressure (Hypertension)
• Allergy to contrast (dye) medium
• Transient Ischemic attack
• Severe anemia
• Electrolyte imbalance
• Uncontrolled rhythm disturbances (arrhythmias)
• Uncompensated heart failure [4] Author details 
